Waldman Lauren P, Nelson Ashley M, Jacobs Jamie M, Gray Tamryn F, Clay Madison, Jagielo Annemarie D, Rice Julia, Traeger Lara, El-Jawahri Areej
Massachusetts General Hospital, Boston, Massachusetts.
Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
Transplant Cell Ther. 2021 Jun;27(6):517.e1-517.e5. doi: 10.1016/j.jtct.2021.03.002. Epub 2021 Mar 5.
Family and friends caring for hematopoietic stem cell transplantation (HCT) recipients experience substantial disruptions in daily life as they prepare for transplant. These disruptions may increase their psychological distress, yet little research has described the extent of this distress. The goals of the present study were to characterize rates of anxiety and depression symptoms immediately prior to HCT and their relationship with modifiable caregiving domains. We conducted a secondary analysis of cross-sectional data of caregivers of patients undergoing HCT. Caregivers completed self-report measures to assess 8 domains of caregiving (Caregiver Oncology Quality of Life Questionnaire) and anxiety and depression symptoms (Hospital Anxiety and Depression Scale [HADS]) prior to transplant. Scores ≥8 on the HADS anxiety and depression subscales signified clinically significant symptoms. We used multivariable regression models adjusting for age, sex, caregiver relationship, and HCT type to examine the associations between caregiving domains and anxiety and depression symptoms. We enrolled 193 caregivers (median age = 60 years, 70.0% female, 52.3% allogeneic transplant). A majority of participants were providing care for a spouse (79.8%), followed by a child (7.8%) or parent (5.2%). On average, caregivers reported more anxiety (mean = 7.04, SD = 3.94) than depression symptoms (mean = 4.18, SD = 3.49), with 46.6% and 16.1% endorsing clinically significant anxiety and depression symptoms, respectively. Caregiver anxiety was associated with worse physical well-being, less leisure time, and poorer coping (Ps < .05). Caregiver depression symptoms were associated with worse physical well-being and less leisure time (Ps < .05). Caregivers of HCT recipients experience substantial psychological distress, particularly anxiety, prior to transplant. This distress is linked to modifiable caregiving domains. Study findings identify possible targets for psychosocial interventions aimed at managing caregiver anxiety and depression symptoms as well as highlight the need for intervention early during the course of transplant.
在为造血干细胞移植(HCT)受者做准备的过程中,照顾他们的家人和朋友的日常生活会受到极大干扰。这些干扰可能会增加他们的心理困扰,但很少有研究描述这种困扰的程度。本研究的目的是确定造血干细胞移植前焦虑和抑郁症状的发生率及其与可改变的照护领域的关系。我们对接受造血干细胞移植患者的照顾者的横断面数据进行了二次分析。照顾者在移植前完成了自我报告测量,以评估8个照护领域(《照顾者肿瘤生活质量问卷》)以及焦虑和抑郁症状(《医院焦虑抑郁量表》[HADS])。HADS焦虑和抑郁分量表得分≥8表示具有临床意义的症状。我们使用多变量回归模型,对年龄、性别、照顾者关系和造血干细胞移植类型进行调整,以检验照护领域与焦虑和抑郁症状之间的关联。我们招募了193名照顾者(中位年龄 = 60岁,70.0%为女性,52.3%为异基因移植)。大多数参与者照顾的是配偶(79.8%),其次是孩子(7.8%)或父母(5.2%)。平均而言,照顾者报告的焦虑症状(均值 = 7.04,标准差 = 3.94)多于抑郁症状(均值 = 4.18,标准差 = 3.49),分别有46.6%和16.1%的人认可具有临床意义的焦虑和抑郁症状。照顾者的焦虑与较差的身体健康、较少的休闲时间和较差的应对能力相关(P < .05)。照顾者的抑郁症状与较差的身体健康和较少的休闲时间相关(P < .05)。造血干细胞移植受者的照顾者在移植前会经历严重的心理困扰,尤其是焦虑。这种困扰与可改变的照护领域有关。研究结果确定了旨在管理照顾者焦虑和抑郁症状的心理社会干预的可能目标,并突出了在移植过程早期进行干预的必要性。